| Cervical Non-Squamous Cell Carcinoma investigated in trials for …INVESTIGATED_IN_TRIALSderived15 of 82show all (up to 200) |
|---|
| → investigated in trials for | Paclitaxelsmall molecule 48 trials (15 active) · roll-up of the cancer and its descendants | — | — | Cervical Non-Squamous Cell Carcinoma | 48 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carboplatinsmall molecule 34 trials (11 active) · roll-up of the cancer and its descendants | — | — | Cervical Non-Squamous Cell Carcinoma | 34 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cisplatinsmall molecule 33 trials (7 active) · roll-up of the cancer and its descendants | — | — | Cervical Non-Squamous Cell Carcinoma | 33 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bevacizumabmonoclonal antibody 31 trials (12 active) · roll-up of the cancer and its descendants | — | — | Cervical Non-Squamous Cell Carcinoma | 31 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fluorouracilsmall molecule 16 trials (0 active) · roll-up of the cancer and its descendants | — | — | Cervical Non-Squamous Cell Carcinoma | 16 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Oxaliplatinsmall molecule 13 trials (2 active) · roll-up of the cancer and its descendants | — | — | Cervical Non-Squamous Cell Carcinoma | 13 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Doxorubicinsmall molecule 12 trials (6 active) · roll-up of the cancer and its descendants | — | — | Cervical Non-Squamous Cell Carcinoma | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Leucovorinsmall molecule 12 trials (0 active) · roll-up of the cancer and its descendants | — | — | Cervical Non-Squamous Cell Carcinoma | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Olaparibsmall molecule 11 trials (9 active) · roll-up of the cancer and its descendants | — | — | Cervical Non-Squamous Cell Carcinoma | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pembrolizumabmonoclonal antibody 11 trials (8 active) · roll-up of the cancer and its descendants | — | — | Cervical Non-Squamous Cell Carcinoma | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Topotecansmall molecule 9 trials (2 active) · roll-up of the cancer and its descendants | — | — | Cervical Non-Squamous Cell Carcinoma | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Gemcitabinesmall molecule 8 trials (4 active) · roll-up of the cancer and its descendants | — | — | Cervical Non-Squamous Cell Carcinoma | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nivolumabmonoclonal antibody 7 trials (5 active) · roll-up of the cancer and its descendants | — | — | Cervical Non-Squamous Cell Carcinoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cediranibsmall molecule 6 trials (6 active) · roll-up of the cancer and its descendants | — | — | Cervical Non-Squamous Cell Carcinoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Irinotecansmall molecule 6 trials (0 active) · roll-up of the cancer and its descendants | — | — | Cervical Non-Squamous Cell Carcinoma | 6 | Observed | clinicaltrials | graph → |